7.02 USD
-0.01 (-0.14%)
7.02 USD
0 (0%)
ACCD gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 100 industry peers in the Health Care Providers & Services industry. The financial health of ACCD is average, but there are quite some concerns on its profitability. While showing a medium growth rate, ACCD is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year ACCD has reported negative net income.
ACCD had a negative operating cash flow in the past year.
In the past 5 years ACCD always reported negative net income.
ACCD had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of -27.85%, ACCD is not doing good in the industry: 83.02% of the companies in the same industry are doing better.
ACCD has a worse Return On Equity (-57.60%) than 72.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -27.85% | ||
| ROE | -57.6% | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 48.15%, ACCD is in the better half of the industry, outperforming 75.47% of the companies in the same industry.
In the last couple of years the Gross Margin of ACCD has grown nicely.
ACCD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 48.15% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.11%
GM growth 5Y5.22%
2. Health
2.1 Basic Checks
ACCD does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for ACCD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
Based on the Altman-Z score of -1.06, we must say that ACCD is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -1.06, ACCD is not doing good in the industry: 82.08% of the companies in the same industry are doing better.
ACCD has a Debt/Equity ratio of 0.67. This is a neutral value indicating ACCD is somewhat dependend on debt financing.
ACCD has a Debt to Equity ratio (0.67) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.06 |
ROIC/WACCN/A
WACC7.47%
2.3 Liquidity
A Current Ratio of 2.63 indicates that ACCD has no problem at all paying its short term obligations.
ACCD has a Current ratio of 2.63. This is amongst the best in the industry. ACCD outperforms 81.13% of its industry peers.
ACCD has a Quick Ratio of 2.63. This indicates that ACCD is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.63, ACCD belongs to the best of the industry, outperforming 81.13% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.63 | ||
| Quick Ratio | 2.63 |
3. Growth
3.1 Past
ACCD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 35.76%, which is quite impressive.
Looking at the last year, ACCD shows a quite strong growth in Revenue. The Revenue has grown by 14.99% in the last year.
Measured over the past years, ACCD shows a very strong growth in Revenue. The Revenue has been growing by 34.31% on average per year.
EPS 1Y (TTM)35.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10.71%
Revenue 1Y (TTM)14.99%
Revenue growth 3Y34.47%
Revenue growth 5Y34.31%
Sales Q2Q%5.73%
3.2 Future
ACCD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.04% yearly.
The Revenue is expected to grow by 13.82% on average over the next years. This is quite good.
EPS Next Y-8.14%
EPS Next 2Y17.4%
EPS Next 3Y15.02%
EPS Next 5Y20.04%
Revenue Next Year13.05%
Revenue Next 2Y12.53%
Revenue Next 3Y12.5%
Revenue Next 5Y13.82%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
ACCD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ACCD. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as ACCD's earnings are expected to grow with 15.02% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.4%
EPS Next 3Y15.02%
5. Dividend
5.1 Amount
No dividends for ACCD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
7.02
-0.01 (-0.14%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners82.6%
Inst Owner Change-22.37%
Ins Owners3.24%
Ins Owner Change0%
Market Cap575.57M
Revenue(TTM)446.72M
Net Income(TTM)-180.30M
Analysts53.75
Price Target6.83 (-2.71%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)45.01%
Min EPS beat(2)32.78%
Max EPS beat(2)57.24%
EPS beat(4)3
Avg EPS beat(4)20.09%
Min EPS beat(4)-38.53%
Max EPS beat(4)57.24%
EPS beat(8)7
Avg EPS beat(8)20.01%
EPS beat(12)10
Avg EPS beat(12)12.6%
EPS beat(16)11
Avg EPS beat(16)2.19%
Revenue beat(2)0
Avg Revenue beat(2)-1.63%
Min Revenue beat(2)-2.56%
Max Revenue beat(2)-0.7%
Revenue beat(4)1
Avg Revenue beat(4)-0.39%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)2.92%
Revenue beat(8)4
Avg Revenue beat(8)-0.07%
Revenue beat(12)8
Avg Revenue beat(12)0.64%
Revenue beat(16)12
Avg Revenue beat(16)1.56%
PT rev (1m)-3.17%
PT rev (3m)-6.66%
EPS NQ rev (1m)-35.39%
EPS NQ rev (3m)-17.28%
EPS NY rev (1m)-7.63%
EPS NY rev (3m)-53.12%
Revenue NQ rev (1m)1.92%
Revenue NQ rev (3m)1.8%
Revenue NY rev (1m)0.54%
Revenue NY rev (3m)0.44%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.29 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.84 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.06
EYN/A
EPS(NY)-0.83
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS5.45
BVpS3.82
TBVpS-0.1
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -27.85% | ||
| ROE | -57.6% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 48.15% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.11%
GM growth 5Y5.22%
F-Score4
Asset Turnover0.69
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 14.12% | ||
| Cap/Sales | 1.34% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.63 | ||
| Quick Ratio | 2.63 | ||
| Altman-Z | -1.06 |
F-Score4
WACC7.47%
ROIC/WACCN/A
Cap/Depr(3y)17.24%
Cap/Depr(5y)23.91%
Cap/Sales(3y)2.06%
Cap/Sales(5y)2.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10.71%
EPS Next Y-8.14%
EPS Next 2Y17.4%
EPS Next 3Y15.02%
EPS Next 5Y20.04%
Revenue 1Y (TTM)14.99%
Revenue growth 3Y34.47%
Revenue growth 5Y34.31%
Sales Q2Q%5.73%
Revenue Next Year13.05%
Revenue Next 2Y12.53%
Revenue Next 3Y12.5%
Revenue Next 5Y13.82%
EBIT growth 1Y36.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year116.25%
EBIT Next 3Y36.45%
EBIT Next 5Y25.67%
FCF growth 1Y72.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y83.28%
OCF growth 3YN/A
OCF growth 5YN/A
ACCOLADE INC / ACCD FAQ
What is the fundamental rating for ACCD stock?
ChartMill assigns a fundamental rating of 3 / 10 to ACCD.
What is the valuation status of ACCOLADE INC (ACCD) stock?
ChartMill assigns a valuation rating of 0 / 10 to ACCOLADE INC (ACCD). This can be considered as Overvalued.
What is the profitability of ACCD stock?
ACCOLADE INC (ACCD) has a profitability rating of 1 / 10.
How financially healthy is ACCOLADE INC?
The financial health rating of ACCOLADE INC (ACCD) is 4 / 10.
What is the earnings growth outlook for ACCOLADE INC?
The Earnings per Share (EPS) of ACCOLADE INC (ACCD) is expected to decline by -8.14% in the next year.